Form 4 for ALNY ALNYLAM PHARMACEUTICALS, INC.
Accepted 2024-08-22 00:00:00 ET · period of report 2024-08-20 · accession 0001735276-24-000085 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-22 | 2024-08-20 | ALNY | Greenstreet Yvonne | CEO, Dir | M - OptEx | $85.00 | +15.0K | 88.4K | +20% | +$1.27M |
| D | 2024-08-22 | 2024-08-20 | ALNY | Greenstreet Yvonne | CEO, Dir | S - Sale+OE | $280.00 | -15.0K | 73.4K | -17% | -$4.20M |
| D | 2024-08-22 | 2024-08-20 | ALNY | Greenstreet Yvonne | CEO, Dir | M - OptEx | $0.00 | -15.0K | 2,352 | -86% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-20 | M | A | 15,000 | $85.00 | 88,441 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-20 | S | D | 15,000 | $280.00 | 73,441 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2024-08-20 | M | D | 15,000 | $0.00 | 2,352 | D | $85.00 · — to 2029-02-27 | 15,000 Common Stock | (F3) This stock option was fully vested and exercisable as of February 28, 2023. |